Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000537486 | SCV000635385 | uncertain significance | Hereditary breast and ovarian cancer syndrome | 2018-11-05 | criteria provided, single submitter | clinical testing | This sequence change replaces serine with arginine at codon 1528 of the BRCA2 protein (p.Ser1528Arg). The serine residue is highly conserved and there is a moderate physicochemical difference between serine and arginine. This variant is present in population databases (rs80359788, ExAC 0.009%). This variant has been reported in an individual with breast cancer (PMID: 24010542). ClinVar contains an entry for this variant (Variation ID: 462348). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV000565812 | SCV000661438 | uncertain significance | Hereditary cancer-predisposing syndrome | 2017-06-22 | criteria provided, single submitter | clinical testing | Lines of evidence used in support of classification: Insufficient evidence |
Color | RCV000565812 | SCV000683632 | uncertain significance | Hereditary cancer-predisposing syndrome | 2018-08-01 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000662564 | SCV000785166 | uncertain significance | Breast-ovarian cancer, familial 2 | 2017-05-17 | criteria provided, single submitter | clinical testing |